Avient (AVNT) Q4 2024 earnings summary

Executive summary

• Achieved 4% organic revenue growth and margin expansion in all regions for 2024, with both business segments posting higher adjusted EBITDA and adjusted EPS of $2.66, up 13%–15% year-over-year including FX impact.

• Launched a new strategy focused on high-growth markets, portfolio prioritization, and new leadership appointments, including a new CTO, CIO, General Counsel, and SVP for business development and marketing.

• Rolled out a new incentive compensation plan in January 2025 to align employee focus with strategic execution.

• 2024 marked the safest year in company history, with record-low injury incident rates.

• Increased dividend by 5% to $1.08 annualized, marking the 14th consecutive year of annual dividend growth.

Financial highlights

• Full-year 2024 sales reached $3,240M, up 3.1% as reported, with organic sales up 4%; adjusted EBITDA was $526M, up 4.9% as reported; adjusted EPS was $2.66, up 12.7%–15% year-over-year.

• Q4 2024 sales were $747M, up 3.8% as reported; Q4 organic sales grew 5% year-over-year.

• Adjusted EBITDA margin expanded 20 basis points to 16.2% for the year.

• Adjusted free cash flow for 2024 was $155.7M, down from $186.3M in 2023.

• Gross margin improved to 32.6% for the year, up from 30.9% in 2023.

Outlook and guidance

• 2025 full-year adjusted EPS guidance is $2.70–$2.94, with midpoint implying 11% growth excluding FX; Q1 2025 adjusted EPS projected at $0.76, with a $0.04 FX headwind.

• 2025 adjusted EBITDA guidance is $540M–$570M, representing 6%–12% growth excluding FX.

• Free cash flow expected between $180M–$200M, with CapEx around $120M, partially offset by ERP project avoidance.

• Margin expansion of 25–75 basis points expected in 2025, with productivity and innovation as key drivers.

• Macro assumptions include Fed rate cuts, Chinese stimulus, and European recovery; risks include inflation, policy uncertainty, and FX volatility.